We developed an optimized Liebeskind–Srogl reaction in order to synthesize potentially biologically active 2-aryl-1, 4-dihydropyrimidines. The pallado-catalyzed cross-coupling reaction between dihydropyrimidines and tributyltin derivatives appears particularly efficient
